Navigation Links
Study finds widespread vitamin and mineral use among cancer survivors
Date:2/1/2008

SEATTLE Use of vitamin and mineral supplements among cancer survivors is widespread, despite inconclusive evidence that such use is beneficial, according to a comprehensive review of scientific literature conducted by researchers at Fred Hutchinson Cancer Research Center and published Feb. 1 in the Journal of Clinical Oncology.

Can vitamin and herbal supplements reduce the adverse effects of cancer treatment, decrease the risk of cancer recurrence or improve a patients chances of survival? We dont really know. Research into these matters has been minimal, said senior author Cornelia (Neli) Ulrich, Ph.D., an associate member of the Hutchinson Centers Public Health Sciences Division. While supplement use may be beneficial for some patients, such as those who cannot eat a balanced diet, research suggests that certain supplements may actually interfere with treatment or even accelerate cancer growth, she said.

In reviewing 32 studies conducted between 1999 and 2006, Ulrich and co-author Christine Velicer, Ph.D., formerly a postdoctoral fellow at the Hutchinson Center (now an epidemiologist at Merck Research Laboratory in North Wales, Pa.), found that many of the nations 10 million adult cancer survivors use nutritional supplements.

They found 64 percent to 81 percent of cancer survivors overall reported using vitamins or minerals (excluding multivitamins), whereas in the general population only 50 percent of adults reported taking dietary supplements.

Survivors of breast cancer reported the highest use (75 percent to 87 percent), whereas prostate-cancer survivors reported the least (26 percent to 35 percent). Factors associated with the highest level of supplement use overall included a higher level of education and being female.

The researchers also found that many people initiate the use of vitamins and supplements after cancer diagnosis; between 14 percent and 32 percent start taking them after learning they have cancer.

Cancer survivors report that they hope to strengthen their immune system with supplement use or gain a sense of control and empowerment, Ulrich said. However, many cancer survivors who use supplements do not let their doctors know; 31 percent to 68 percent of cancer patients and survivors who use supplements may not disclose this information or their doctors may fail to record it in their charts.

This is disconcerting and suggests that many physicians may not recognize the importance of understanding whether their patients are taking supplements, Ulrich said.

Knowing about supplement use is crucial, she continues, because of potential adverse effects. Evidence clearly suggests the need for caution, Ulrich said. Some vitamins, such as folic acid, may be involved in cancer progression while others, such as St. Johns wort, can interfere with chemotherapy. However, we really need more research to understand whether use of these supplements can be beneficial or do more harm than good.

Until research clarifies the effects of vitamin use in cancer survivors, the authors urge health care professionals to communicate openly with their patients about supplement use. A simple explanation that medical studies show supplement use may not always be beneficial may help cancer survivors make well-informed decisions, the authors wrote.


'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related medicine news :

1. New Study Shows Isolaz Can Reduce Acne Up to 90 Percent
2. Journal Sleep: Study concludes a daytime nap can benefit a persons memory performance
3. MITs McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia
4. Study Spots Gene That Plays Role in Infertility
5. Kiadis Pharma Announces Successful Completion of Rhitol(TM) Phase II Clinical Study
6. Top hospitals have 27 percent lower mortality, annual HealthGrades study finds
7. Study reveals improved prediction of prostrate cancer
8. Porous structures help boost integration of host tissue with implants, study finds
9. UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets
10. Study paves way for development of macular degeneration cures
11. Study Challenges New Benchmark for High-Volume Heart Transplant Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... 19, 2017 , ... Big Barker , a Philadelphia-based ... 2016 donation of dog beds to the K9 officers of the Allentown, Pennsylvania ... its contribution from city and state officials. , The U.S. House of ...
(Date:9/19/2017)... Montclair, NJ (PRWEB) , ... September 19, 2017 ... ... fall following the success of the annual PAINWeek National Conference. On October 7, ... will be an educational and exciting program providing busy clinicians and allied healthcare ...
(Date:9/19/2017)... ... 2017 , ... Bone Solutions Inc. (BSI), an orthobiologics technology ... device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with bone repair ... critical property for bone health and development. , “We’re excited to bring this ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Premiere Long Island ... Sami, was recently named one of the best dentists in America under age 40 ... dental professionals nationwide. Every fall, the magazine features the best 40 dentists under the ...
(Date:9/19/2017)... ... September 19, 2017 , ... Inc. magazine ranked ... ranking of the nation's fastest-growing private companies. The list represents a unique look ... independent small and midsized businesses. Endo-Systems is a leading B2B distributor of today’s ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)...   OrthoAtlanta has been named the official orthopedic ... (AFHC) for the 2018 College Football Playoff (CFP) National Championship ... Stadium in Atlanta, Georgia . OrthoAtlanta is ... campaign, participating in many activities leading up to, and including ... ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology: